Identification of SLC3A2 as a Potential Therapeutic Target of Ferroptosis in Bladder Cancer. Yang Q, Zhou D, Beasley A, Liu Y, et al. Arch Esp Urol 2026;79:36-48.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang Q, Zhou D, Beasley A, Liu Y, et al. Identification of SLC3A2 as a Potential Therapeutic Target of Ferroptosis in Bladder Cancer. Arch Esp Urol 2026;79:36-48.
PMID: 41775351